Important note

This AI stock analysis for Synopsys is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Synopsys - AI Stock Analysis

Analysis generated December 23, 2024

Synopsys, Inc. is a leading company in the technology sector, providing electronic design automation (EDA) solutions that assist in the design and verification of semiconductor devices. The company offers a comprehensive portfolio of software tools and services that facilitate the design and testing of integrated circuits, making it an essential player in the semiconductor and systems design automation industry.

Fundamental Analysis

The revenue for Synopsys in the last quarter was $1.64 billion, representing a 7.23% increase compared to the previous quarter. This growth is a positive indicator of the company's expanding business activities. Further comparison to the same quarter last year shows a 2.30% increase, which signals consistent year-over-year growth in revenue.

Net income for the last quarter was $1.11 billion. This figure marks an impressive increase of 173.03% from the previous quarter, underscoring significant profitability expansion. The year-over-year comparison shows an even more astounding rise of 219.05%, indicating robust financial health and growth trajectory.

EBITDA for the last quarter was $1.14 billion, reflecting a 177.69% rise from the previous quarter and a 152.80% increase year-over-year. These figures suggest strong operational efficiency and profitability.

The current P/E ratio stands at 53.21, which is relatively high. A high P/E ratio could imply overvaluation of the stock, which may temper investor enthusiasm due to potential bearish implications.

Technical Analysis

Today's stock price for Synopsys is $496.25, which is down by 12.18% compared to a month ago and down by 5.38% year-over-year. This declining trend may be concerning in both the short and long term.

The simple moving average (SMA10) is currently at $501.11, slightly lower than the previous SMA10 of $502.31. This lower SMA10 value suggests potential downward momentum in the stock's price movement.

The Relative Strength Index (RSI) is at 0, indicating that the stock might be oversold. An oversold condition often points to a potential bullish reversal, suggesting that the stock could be poised for a price increase if market conditions improve.

Alternative Data Analysis

Analyzing alternative data, the business outlook among Synopsys employees is neutral, which implies neither strong optimism nor pessimism within the company.

The company's website saw an estimated 1 million visitors in the last month; however, this represents a 17% decline over the past couple of months. This reduction in web traffic may indicate a potential decline in customer interest or engagement, which is a point of concern.

Synopsys' Instagram following has grown by 7% to 5,500 followers, signaling a rising interest in the company's brand. On Twitter, the company maintains 23,000 followers, with no significant changes over recent months.

According to AltIndex's AI score, Synopsys holds a score of 52, which translates to a "hold" signal. This AI-driven assessment considers fundamental, technical, and alternative data, advocating a neutral stance toward the company's stock.

Conclusion and Recommendation

In summary, Synopsys shows strong financial health with significant growth in revenue, net income, and EBITDA. However, the high P/E ratio might indicate overvaluation concerns. The technical indicators suggest potential short-term bearish trends, balanced by an oversold RSI value hinting at a potential price reversal.

Alternative data presents a mixed outlook, with declining website traffic contrasted by increasing social media engagement. The overall recommendation, supported by AltIndex's AI score of 52, is to hold the stock, considering the current mixed signals and the need for careful monitoring of future developments.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.